Skip to content

Updates and Current Landscape for Study Population Selection and Additional Mitigation Strategies in Bioequivalence Studies



Presenters

Karen Li, PharmD
Pharmacologist
DTPII | ORS | OGD | CDER | FDA

Duyen Nguyen, PharmD
Pharmacologist
DTPII | ORS | OGD | CDER | FDA

Leave a Comment

Your email address will not be published. Required fields are marked *